|
Since 1989, Athena Diagnostics, Inc. has been a leader in clinical laboratory diagnostics for neurological disease. Now, Athena is proud to bring their proven history of innovation, technological acumen and expertise to the field of renal disease. The April 2001 launch of PKDx™, Athena's assay for polycystic kidney disease, underlines our commitment to our continuing tradition of innovation in clinical reference testing, as well as our commitment to this new medical specialty.
Explore these pages for the latest information on our new testing services in nephrology. Be sure to check back often - we are constantly seeking out discoveries for new testing services, and work to bring them into the hands of healthcare professionals as rapidly as we can.
 More information
|
 |
 |
|
NEW! Interstitial Kidney Disease testing now available. Alterations in the Tamm-Horsfall protein have been shown to be associated with familial hereditary juvenile (or gouty) nephropathy and medullary cystic kidney disease type II.
 More
Info |
| |
|
|
NEW! Nephrotic Syndrome profile now available. Now
you can save time and money with an economical
evaluation of both the NPHS1 and
NPHS2 genes. More
Info |
| |
|
|
NEW! PKDx family testing (single
amplicon) now available. For transplant evaluation,
family members who wish to know the
genetic cause of their disease and
other indications.
More
Info |
| |
|
